Non-Hodgkin Lymphoma
Conference Coverage
EMA Greenlights Four Drugs for Bladder and Other Cancers
Among the drug approvals the CHMP endorsed was Balversa for the treatment of urothelial carcinoma.
Feature
Oncology Mergers Are on the Rise. How Can Independent Practices Survive?
The number of community practices acquired by hospitals nearly tripled from 2010 to 2020, according to a report from COA.
Feature
Doctors Endorsing Products on X May Not Disclose Company Ties
Researchers review posts by physicians on X, looking for key words that might indicate that the posts were intended as endorsements of a product...
Conference Coverage
One Patient Changed This Oncologist’s View of Hope. Here’s How.
“How we think about hope directly influences patient care,” according to a professor of clinical medicine at Weill Cornell Medicine in New York...
From the Journals
Are Children Born Through ART at Higher Risk for Cancer?
A slight increase in the risk for leukemia was observed in children conceived through IVF or ICSI.
Feature
The ASCO Annual Meeting Starts This Week
More than 7000 abstracts were submitted for this year’s meeting a new record — and over 5000 were selected for presentation.
From the Journals
ASTRO Releases New EBRT Guideline for Symptomatic Bone Mets
Recommendations concerning pain management and quality of life are part of the guidance.
Feature
Obesity and Cancer: Untangling a Complex Web
Is gaining weight later in life better or worse for cancer risk than being overweight or obese from a young age?
Feature
Does More Systemic Treatment for Advanced Cancer Improve Survival?
Researchers evaluate whether patients treated in practices with higher rates of systemic therapy for very advanced disease have longer survival....
Feature
Urine Tests Could Be ‘Enormous Step’ in Diagnosing Cancer
Cancer biomarkers in urine are not nearly as widely studied as those in the blood, but a new wave of urine tests suggests research is gaining pace...
Feature
Chatbots Seem More Empathetic Than Docs in Cancer Discussions
AI gives readable, high quality, and empathetic responses to social media queries about cancer.